Titration of carvedilol in elderly heart failure patients

Area of Science:

• Cardiology
• Geriatrics
• Pharmacology

Background:

• Physicians often hesitate to prescribe beta blockers, such as carvedilol, to elderly heart failure patients due to concerns about tolerability.
• This perception may lead to underutilization of beneficial therapies in a vulnerable population.

Purpose of the Study:

• To compare the success and tolerability of carvedilol titration in elderly (≥70 years) versus younger (<70 years) heart failure patients.
• To evaluate whether age is a significant barrier to achieving target or partial carvedilol dosages.

Main Methods:

• A study involving 360 heart failure patients undergoing carvedilol titration.
• Patients were divided into two groups: elderly (≥70 years) and younger (<70 years).
• Titration success, dosage achieved, duration, and adverse events were compared between groups, with dosage adjusted for body weight.

Main Results:

• While the mean achieved carvedilol dosage was lower in elderly patients, this difference disappeared when adjusted for body weight.
• Target dosage achievement was slightly lower in the elderly group (55.3%) compared to the younger group (62.0%), but partial doses were achieved by a higher percentage of elderly patients (44.7%).
• Adverse events were more frequent in the elderly but did not significantly impede titration duration or weight-adjusted dosage.

Conclusions:

• Carvedilol titration is feasible and generally well-tolerated in elderly heart failure patients.
• Age alone should not be a reason to withhold carvedilol therapy.
• Further research may explore baseline characteristics influencing titration outcomes in diverse age groups.